Related Experiment Video
Updated: Oct 12, 2025

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
A case of tocilizumab-refractory idiopathic multicentric Castleman's disease successfully treated with sirolimus
Remi Sumiyoshi1, Tomohiro Koga2, Kaori Furukawa3
1Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan; Nagasaki University Hospital, Clinical Research Center, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Abstract:
mTOR signaling may be a new therapeutic target for IL-6 inhibitor refractory iMCD-NOS.
More Related Videos
10:31Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
Published on: August 13, 2017
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Pericarditis III: Medical Management
Treatment Resistant Cancers
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Myocarditis III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF